-transparent.png){kind=logo}
Benoxaprofen did not impair platelet function or platelet prostaglandin synthesis in vivo or in vitro in contrast to indomethacin, a known prostaglandin synthesis inhibitor. Platelet cyclic AMP levels were not changed by either drug in vivo or in vitro. The results of routine tests for hemostatic function (template bleeding time and blood clotting assays) were not changed by either drug. A trend towards inhibition of cAMP-dependent protein kinase by benoxaprofen was observed. The significance of this observation, if valid, remains obscure. These studies suggest that benoxaprofen, which does not appreciably suppress hemostatic function, may be used safely in patients with acquired or congenital coagulation defects (e.g. patients receiving oral anticoagulant, hemophiliacs with arthropathy).
N U Bang, and
A M Dwyer, and
C A Marks, and
L E Mattler, and
R O Heidenreich, and
S S Campbell, and
A S Ridolfo
December 1984,
Inflammation,
N U Bang, and
A M Dwyer, and
C A Marks, and
L E Mattler, and
R O Heidenreich, and
S S Campbell, and
A S Ridolfo
June 1977,
The Journal of pharmacy and pharmacology,
N U Bang, and
A M Dwyer, and
C A Marks, and
L E Mattler, and
R O Heidenreich, and
S S Campbell, and
A S Ridolfo
June 1984,
The Journal of rheumatology,
N U Bang, and
A M Dwyer, and
C A Marks, and
L E Mattler, and
R O Heidenreich, and
S S Campbell, and
A S Ridolfo
October 1971,
Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology,
N U Bang, and
A M Dwyer, and
C A Marks, and
L E Mattler, and
R O Heidenreich, and
S S Campbell, and
A S Ridolfo
October 1993,
The Journal of laboratory and clinical medicine,
N U Bang, and
A M Dwyer, and
C A Marks, and
L E Mattler, and
R O Heidenreich, and
S S Campbell, and
A S Ridolfo
November 2007,
Molecular nutrition & food research,
N U Bang, and
A M Dwyer, and
C A Marks, and
L E Mattler, and
R O Heidenreich, and
S S Campbell, and
A S Ridolfo
January 1975,
Minerva nefrologica,
N U Bang, and
A M Dwyer, and
C A Marks, and
L E Mattler, and
R O Heidenreich, and
S S Campbell, and
A S Ridolfo
November 1994,
Journal of clinical pharmacology,
N U Bang, and
A M Dwyer, and
C A Marks, and
L E Mattler, and
R O Heidenreich, and
S S Campbell, and
A S Ridolfo
January 1980,
The Journal of rheumatology. Supplement,
N U Bang, and
A M Dwyer, and
C A Marks, and
L E Mattler, and
R O Heidenreich, and
S S Campbell, and
A S Ridolfo
June 1985,
Immunological investigations,
